Table 5.

Multivariate logistic regression analysis of hospital outcomes in comparison to patients not receiving multimodal analgesia.

Multimodal Group	Odds Ratio	OR 95% CI	P-Value
Outcome: Hospital LOS ≥2 Days
Group 2 Acetaminophen Only	0.464	0.262–0.822	0.009
Group 3 Acetaminophen with Pregabalin/Gabapentin Only	0.360	0.223–0.580	<0.001
Group 4 Celecoxib with Acetaminophen or Pregabalin/Gabapentin	0.164	0.049–0.553	0.004
Group 5 Full Multimodal – Celecoxib, Acetaminophen, and Pregabalin/Gabapentin	0.398	0.269–0.590	<0.001
Outcome: Hospital OMME ≥ 75thPercentile
Group 2 Acetaminophen Only	0.558	0.357–0.871	0.010
Group 3 Acetaminophen with Pregabalin/Gabapentin Only	0.375	0.262–0.535	<0.001
Group 4 Celecoxib with Acetaminophen or Pregabalin/Gabapentin	0.524	0.272–1.009	0.053
Group 5 Full Multimodal – Celecoxib, Acetaminophen, and Pregabalin/Gabapentin	0.351	0.258–0.478	<0.001

P-Value <0.05 in bold.

Adjusted Odds Ratio controlling for age, BMI, non-white race, diabetes mellitus, CAD, GERD, ASA ≥3, spinal anesthesia.